YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin

MLA

Haruo Kato, et al. “YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin.” Anticancer Research, vol. 37, no. 1, Nov. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....275b7d5372c33720ec087f3497673cf8&authtype=sso&custid=ns315887.

APA

Haruo Kato, Takeshi Miyao, Yoshiyuki Miyazawa, Yosuke Furuya, Hidekazu Koike, Kazuhiro Suzuki, Yoshitaka Sekine, & Takashi Nitta. (2016). YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin. Anticancer Research, 37(1).

Chicago

Haruo Kato, Takeshi Miyao, Yoshiyuki Miyazawa, Yosuke Furuya, Hidekazu Koike, Kazuhiro Suzuki, Yoshitaka Sekine, and Takashi Nitta. 2016. “YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin.” Anticancer Research 37 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....275b7d5372c33720ec087f3497673cf8&authtype=sso&custid=ns315887.